Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Share-based Compensation: 2010-2024

Historic Share-based Compensation for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to $36.7 million.

  • EyePoint Pharmaceuticals' Share-based Compensation rose 395.45% to $780,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $3.2 million, marking a year-over-year increase of 23.57%. This contributed to the annual value of $36.7 million for FY2024, which is 204.72% up from last year.
  • EyePoint Pharmaceuticals' Share-based Compensation amounted to $36.7 million in FY2024, which was up 204.72% from $12.1 million recorded in FY2023.
  • EyePoint Pharmaceuticals' Share-based Compensation's 5-year high stood at $36.7 million during FY2024, with a 5-year trough of $5.5 million in FY2020.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Share-based Compensation value was $14.2 million (recorded in 2022), while the average stood at $21.0 million.
  • In the last 5 years, EyePoint Pharmaceuticals' Share-based Compensation declined by 14.95% in 2023 and then skyrocketed by 204.72% in 2024.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Share-based Compensation stood at $5.5 million in 2020, then skyrocketed by 34.25% to $7.4 million in 2021, then soared by 90.37% to $14.2 million in 2022, then declined by 14.95% to $12.1 million in 2023, then skyrocketed by 204.72% to $36.7 million in 2024.